Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium
Despite significant global efforts, disparities in oral health outcomes, access to dental care, and standardization across dental education, practices, and policies persist. The D20 Workshop brought together leading experts, policymakers, academic leaders, and industry stakeholders from India and representatives from key international organizations including Fédération Dentaire Internationale (FDI World Dental Federation) along with FDI World Dental Federations of European Regional Organisation (ERO), African Regional Organisation (ARO), Asia Pacific Regional Organisation (APRO), Latin American Regional Organisation (LARO) and North American Regional Organisation (NARO).
Smt. Anupriya Patel, Minister of State for Health and Family Welfare, Govt. of India, added, "The Government of India recognizes the critical importance of oral health to the nation's overall well-being. We are dedicated to supporting initiatives that strengthen our oral healthcare infrastructure and improve health outcomes for our citizens, and this workshop was a testament to that commitment."
"Oral health is a fundamental component of overall well-being, yet significant disparities remain globally," stated Dr. Ashok Dhoble, Hon. Secretary General, IDA . "The D20 International Workshop proved to be a crucial step forward in driving better oral health outcomes and improving oral health statistics for India and beyond. By convening diverse international stakeholders, we successfully established stronger guidelines and developed robust policies for oral healthcare worldwide."
"The FDI is committed to advancing oral health globally, and initiatives like the D20 Workshop are vital for fostering the collaboration needed to achieve our Vision 2030 goals," said Mr. Enzo Bondioni, Executive Director, FDI. "We are pleased with the productive discussions that took place, which will undoubtedly translate into tangible improvements in oral healthcare access and quality for all."
The workshop addressed three critical areas:
1. Learning from International Best Practices and Leveraging Successful Implementation Strategies through Collaboration: Discussions focused on addressing challenges in translating oral health policies into effective action by fostering trans-border collaboration and adopting proven strategies.
2. Advocating Integration of Innovative Models of Prevention and Early Detection into Healthcare Systems: The workshop highlighted the immense economic and public health benefits of preventive care, with a focus on integrating cutting-edge technology and industry participation to mitigate oral health risks.
3. Identifying and Addressing Gaps in Standardization across Dental Education, Research, Clinical Practice, and Policy Frameworks: Building on previous national discussions, this workshop extended efforts to establish globally accepted best practices and benchmarks for dental healthcare systems.
Mr. Navneet Saluja, BU GM, Haleon ISC, added "At Haleon, we firmly believe that oral health is intrinsically linked to overall well-being, yet it often doesn't receive the attention it deserves. Our collaboration with the Indian Dental Association for the D20 International Workshop underscored our unwavering commitment to transforming oral healthcare in India and beyond, through sustained awareness, education, and accessible solutions that align with our purpose of delivering better everyday health with humanity."
The D20 International Workshop proved to be a landmark event, fostering research, technology development, and partnership building to advance oral healthcare access and outcomes globally.
About Haleon India (erstwhile GlaxoSmithKline Consumer Healthcare):
Haleon in India is a leading fast-moving consumer healthcare company with a clear purpose to deliver better everyday health with humanity. Currently, Haleon India is operating in oral care, digestive health, pain management and respiratory, and Vitamin Mineral Supplement with iconic brands such as Sensodyne, Paradontax, Polident, Eno, Iodex, Crocin, Otrivin, Centrum and Ostocalcium.
(Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
21 hours ago
- Business Standard
Manipal Hospital Varthur Hosts Breastfeeding Awareness Event to Guide Families Through Early Parenthood
PRNewswire Bengaluru (Karnataka) [India], August 6: On the occasion of World Breastfeeding Week, celebrated annually from 1st to 7th August, the Department of NICU & Pediatrics at Manipal Hospital Varthur Road conducted a breastfeeding awareness event for new and expectant parents on Saturday, 2nd August 2025. Members from different RWAs in Varthur attended and participated in the insightful session led by consultants Dr. Anand Patil, Consultant - NICU and Pediatrics, and Dr. Prachi Kathuria Gera, Consultant - Lactation. The event aimed to support, promote and empower mothers to understand and overcome the challenges faced during motherhood. It covered a wide range of topics, including the benefits of breastmilk and skin-to-skin contact between mother and baby, as well as tips on proper latching and holding techniques. Speaking at the event, Dr. Anand Patil said, "In the initial days, breastmilk is secreted in the form of a rich, yellow liquid known as colostrum, which is packed with antibodies, particularly secretory IgA. These antibodies coat the baby's intestinal wall, helping to strengthen the immune system and prevent infections. Skin-to-skin contact is also essential as it enhances bonding between mother and baby." Highlighting the signs of adequate breastfeeding, Dr. Prachi Kathuria Gera remarked, "After your baby is born, key indicators to monitor include sufficient urine output--at least 6 units per day, regular stools, healthy weight gain after the first week, and visible post-feeding satisfaction. The mother should also not experience any pain during breastfeeding. While mild discomfort during the first couple of days is normal, persistent pain is a red flag and should be addressed immediately." The event garnered enthusiastic participation from attendees, who engaged in interactive activities and a Q & A session with the experts. This was followed by a panel discussion featuring Dr. Anand Patil; Dr. Prachi Kathuria Gera; Dr. Bhakyalakshmi, Consultant - Paediatrics; Dr. Tanuja Mishra, Consultant - Paediatrics; and Dr. Vijaya Meenakshi, Consultant - OBG. Dr. Anand Patil highlighted the importance of breastmilk, stating that it is not a static fluid but is one of nature's most intelligent and adaptive nutritional systems tailored to the baby's needs: "Let's create a culture where every mother feels confident, every baby feels nurtured and one where breastfeeding is seen not as feeding--but as the first act of lifelong care." Dr. Prachi Kathuria Gera also emphasized that breastfeeding isn't solely a mother's responsibility but a shared commitment: "When we create a respectful, informed, and consistent support system around her, we don't just nourish a baby--we strengthen a family and future generations." The session concluded with new and soon-to-be-parents leaving their handprints on the breastfeeding pledge wall, as a symbol of their support and celebration. The hospital's dedicated breastfeeding room was also inaugurated. For more information, please visit: Photo: Photo:
The Wire
a day ago
- The Wire
Everhope Oncology Launches First Cancer Daycare Centre in Gurugram — Revolutionizing Cancer Care with Compassion, Precision and Convenience
Everhope Oncology takes the anxiety out of cancer treatment — with zero wait time, 2X faster service, pre-booked diagnostics, and personalised concierge-led assistance. GURUGRAM, India, Aug. 6, 2025 /PRNewswire/ -- Everhope Oncology, a next-generation cancer care platform backed by Narayana Health, W Health Ventures, and 2070 Health, today announced the launch of its first 15-bed dedicated cancer daycare centre in Sector 65, Gurugram. Situated strategically on Golf Course Extension Road, this state-of-the-art facility transforms how cancer care is delivered in India — especially for cancer patients who desire seamless, personalized treatment without compromising their quality of life. Everhope provides clinical excellence in a non-hospital, healing-led environment. More than a facility, Everhope is a bold movement to redefine cancer care — from fear and confusion to clarity, convenience, and dignity. "This is not just a launch of another healthcare facility. It's a response to what millions of Indian patients need — accessible, dignified cancer care that doesn't uproot their entire lives," said Gaurav Porwal, Director, Everhope Oncology. "We are solving India's cancer care gaps by reimagining the entire experience — from long queues and hospital overwhelm to a centre that's calm, close to home, and clinically world-class. Our daycare model eliminates the logistical and emotional barriers that often delay or complicate treatment. Patients can receive their chemotherapy in the morning and return to their normal activities by afternoon. And, what also sets us apart is our focus on personalized nutrition guidance from functional medicine experts, tailored to each patient's unique needs. This expert support not only aids recovery but also helps optimize treatment outcomes — ensuring that every patient receives holistic care, not just medical intervention. With the demand for 40,000 new cancer beds projected in India over the next few years, we believe the Everhope model is timely, viable, and scalable." Cancer care is evolving — globally and in India. While earlier, treatments required long hospital stays and multiple visits to distant tertiary centres, the daycare model is now considered the gold standard in high-income countries. Over 60% of chemotherapy and immunotherapy sessions worldwide are delivered via daycare — enabling patients to recover at home, maintain routine, and reduce exposure to hospital-borne infections. India, however, faces a growing cancer burden — with 8 million active cases, and 1 in 9 Indians projected to develop cancer in their lifetime. Coupled with a doctor-patient ratio of 1 oncologist for every 2,000 patients, delays in diagnosis and treatment are common. Everhope bridges this critical gap by bringing precision oncology closer to the patient, while reducing logistical stress and psychological barriers. "Our clinical offering isn't just comprehensive — it's cohesive," said Dr. Sunny Garg, Chief Medical Officer, Everhope Oncology. "With a high-powered Tumor Board, protocol adherence, and patient tracking systems, we ensure every treatment is tailored, evidence-backed, and emotionally intelligent. Whether it's immunotherapy, palliative care, or integrative support — we aim to deliver world-class outcomes centred around the patients in a neighbourhood setting. Cancer patients shouldn't have to choose between world-class treatment and maintaining their quality of life. Our daycare model recognizes that these patients want to continue working, spending time with family, and sleeping in their own beds. Research shows that outpatient chemotherapy not only maintains equivalent clinical outcomes but often improves patient satisfaction and psychological well-being." Everhope Oncology raised $10 million in seed funding, making it one of the largest early-stage investments in Indian healthcare in recent years. The joint venture brings together clinical excellence from Narayana Health, venture innovation from W Health, and GTM and Technology capabilities from 2070 Health. After the successful launch of the Gurugram centre, Everhope plans to open additional centres across NCR, including South Delhi and Noida in the coming months. The brand is also finalising locations in Mumbai and Bangalore, with a 10-city expansion roadmap planned over the next three years. With a mission to deliver 100,000 cancer sessions over the next 36 months, Everhope is poised to reshape how India treats, manages, and overcomes cancer — with dignity, speed, and strength. Everhope's unique edge • 15-bed private suites designed for chemotherapy and targeted therapy • 24x7 patient concierge support for appointment management and care continuity • 2x time saving at every stage from diagnostics to therapy, during consultation, billing and also parking • On-demand diagnostics with pre-booked lab & imaging services • Financial assistance cell for insurance, EMIs, and cost transparency • A Super Specialist Tumor Board of oncologists across medical, surgical, and radiation specialties • Precision Oncology Pathways with protocol-driven care and clinical audits • Mental health Emotional support and counselling for patients and next of kin • Customised Nutrition: Patients receive tailored meal plans designed by onco-nutrition experts to aid recovery and boost immunity About Everhope Oncology: Everhope is India's first specialised cancer daycare brand committed to transforming how cancer care is experienced and delivered. It's focused on delivering holistic, localised, and emotionally intelligent oncology care. From chemotherapy to counselling, diagnostics to diet, Everhope builds a 360-degree support ecosystem — centred entirely around the patient. Everhope Oncology is India's first patient-first, technology-enabled cancer daycare platform committed to transforming how cancer care is experienced and delivered. Founded in 2025 as a joint venture between Narayana Health, W Health Ventures, and 2070 Health, Everhope focuses on delivering high-quality, decentralised cancer treatment through accessible, emotionally intelligent, and clinically robust facilities. Each Everhope centre is designed to offer same-day chemotherapy, immunotherapy, diagnostics, nutrition, mental health counselling, and concierge support — all under one roof. With zero wait times, expert-led tumor boards, and integrated care pathways, Everhope aims to reduce the logistical, financial, and emotional burdens typically associated with cancer treatment. The brand's vision is to expand across 10 cities in the next three years, bringing compassionate, world-class oncology care closer to where people live and work. For more information, visit: (Disclaimer: The above press release comes to you under an arrangement with PRNewswire and PTI takes no editorial responsibility for the same.).
Time of India
a day ago
- Time of India
Thousands of medical seats are going vacant: What's really wrong with MBBS admissions in India?
India has seen a substantial rise in MBBS seats, from 83,275 in 2020–21 to 1,15,900 in 2024–25, yet the number of unfilled undergraduate medical seats remains a concern. On August 1, data shared in the Lok Sabha by Anupriya Patel, Minister of State in the Ministry of Health and Family Welfare, confirmed that underutilisation of seats persists across medical colleges (excluding AIIMS and JIPMER), despite expanded capacity. The statistics were presented in response to an unstarred question raised by Telugu Desam Party MP Putta Mahesh Kumar and were sourced from the National Medical Commission (NMC). The highest number of vacancies was recorded in 2022–23 with 4,146 seats remaining unfilled. This number dropped to 2,959 in 2023–24 and further declined to 2,849 in the 2024–25 academic cycle. In 2021–22, 2,012 seats were vacant. Vacant UG Seats (Excluding AIIMS & JIPMER) 2021–22: 2,012 2022–23: 4,146 2023–24: 2,959 2024–25: 2,849 What's driving the expansion in MBBS seats? The government attributes the 39% increase in seats to three main factors: Opening of new medical colleges Improvements in faculty availability Strengthening of institutional infrastructure To ensure quality, the NMC has introduced the Minimum Standard Requirement Regulations, 2023, which prescribe benchmarks for infrastructure, clinical material, faculty, and facilities for establishing and maintaining medical colleges. Which states saw the biggest jump in seats? According to government data, states like Uttar Pradesh, Tamil Nadu, Karnataka, Maharashtra, and Gujarat have added the most seats between 2020–21 and 2024–25. Smaller states and Union Territories have also seen increases. For instance: Arunachal Pradesh went from 50 to 100 seats Manipur from 225 to 525 Nagaland from 0 to 100 Meghalaya from 50 to 150 Full list of MBBS seat expansion by State/UT State/UT 2020–21 2024–25 Andaman & Nicobar 100 114 Andhra Pradesh 5,210 6,585 Arunachal Pradesh 50 100 Assam 1,050 1,700 Bihar 2,140 2,995 Chandigarh 150 150 Chhattisgarh 1,345 2,105 Dadra & Nagar Haveli 150 177 Delhi 1,422 1,346 Goa 180 200 Gujarat 5,700 7,000 Haryana 1,660 2,185 Himachal Pradesh 920 920 Jammu & Kashmir 1,135 1,385 Jharkhand 780 1,055 Karnataka 9,345 12,194 Kerala 4,105 4,705 Madhya Pradesh 3,585 4,900 Maharashtra 9,000 11,844 Manipur 225 525 Meghalaya 50 150 Mizoram 100 100 Nagaland 0 100 Odisha 1,950 2,675 Puducherry 1,530 1,873 Punjab 1,425 1,699 Rajasthan 4,200 6,279 Sikkim 50 150 Tamil Nadu 8,000 12,000 Telangana 5,240 8,915 Tripura 225 400 Uttar Pradesh 7,428 12,325 Uttarakhand 825 1,350 West Bengal 4,000 5,699 Why do MBBS seats continue to go unfilled? Despite the steady expansion in capacity, several systemic and structural factors contribute to the underutilisation of available undergraduate medical seats: High cost of private medical education: While government colleges remain highly sought-after, a large number of candidates find private options financially out of reach. For students who miss out on a government seat, the cost barrier becomes a deciding factor. Complex counselling and sudden withdrawals: Complicated state-level counselling procedures, delayed decisions by candidates, and last-minute withdrawals can disrupt the allocation process and leave seats unfilled. Limited support in marginalised regions: Students from rural or underserved areas often face a lack of proper guidance during the admission process, reducing their chances of successfully securing a seat through counselling. Perceived gaps in institutional quality: Many candidates prioritise well-established or high-ranking colleges. As a result, newly established or less popular institutions may see a higher proportion of vacant seats despite having the required infrastructure. What steps is the government taking? According to the Ministry, the government is implementing multiple strategies to further boost the number of seats while maintaining educational standards. Centrally sponsored scheme: A key initiative involves converting district and referral hospitals into medical colleges. So far, 157 medical colleges have been approved under this scheme, and 131 are already operational. These efforts are targeted particularly at underserved and aspirational districts. Capacity building in existing colleges: Another central scheme is focused on expanding infrastructure in existing state and central government medical colleges. This is aimed at increasing both MBBS and postgraduate (PG) seat capacity. Pradhan Mantri Swasthya Suraksha Yojana (PMSSY): As part of this scheme, 75 government medical colleges are being upgraded through the addition of Super Speciality Blocks. Of these, 71 projects have been completed. Expansion of AIIMS: Under the central sector scheme, 22 All India Institutes of Medical Sciences (AIIMS) have been approved. Undergraduate courses have already begun in 19 of them. The steady increase in MBBS seats points to the government's sustained focus on expanding healthcare education. However, the persistence of vacant seats, even with the rising capacity, raises questions about admission processes, affordability, regional distribution of institutions, and the preparedness of students to meet eligibility criteria. As infrastructure improves and access broadens, the next steps may lie in addressing why seats are left vacant even when the demand for medical education remains high. TOI Education is on WhatsApp now. Follow us here.
